Alice Neimantaite

Alice Neimantaite

Auto-generated profile, based on publicly available information

Alice Neimantaite

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg , Gothenburg

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Neuro-Oncology Advances
Verified
Journal Article
Open access
PDF file
TVTomás Gomez Vecchio
Tomás Gomez Vecchio
ANAlice Neimantaite
Alice Neimantaite
ETErik Thurin
Erik Thurin
Julia FurtnerJulia Furtner
Julia Furtner
OSOle Solheim
Ole Solheim
AJAsgeir Jakola
Asgeir Jakola
Radiologically presumed diffuse lower-grade glioma (dLGG) are typically non or minimal enhancing tumors, with hyperintensity in T2w-images. The aim of this study was to test the clinical usefulness of deep learning (DL) in IDH mutation prediction in patients with radiologically presumed dLGG. Three hundred and fourteen patients were retrospectively recruited from 6 neurosurgical departments in Sweden, Norway, France, Austria, and the United States. Collected data included patients’ age, sex, tumor molecular characteristics (IDH, and 1p19q), and routine preoperative radiological images. A clinical model was built using multivariable logistic regression with the variables age and tumor location. DL models were built using MRI data only, and 4 DL architectures used in glioma research. In the final validation test, the clinical model and the best DL model were scored on an external validation cohort with 155 patients from the Erasmus Glioma Dataset. The mean age in the recruited and external cohorts was 45.0 (SD 14.3) and 44.3 years (SD 14.6). The cohorts were rather similar, except for sex distribution (53.5% vs 64.5% males, P-value = .03) and IDH status (30.9% vs 12.9% IDH wild-type, P-value <.01). Overall, the area under the curve for the prediction of IDH mutations in the external validation cohort was 0.86, 0.82, and 0.87 for the clinical model, the DL model, and the model combining both models’ probabilities. In their current state, when these complex models were applied to our clinical scenario, they did not seem to provide a net gain compared to our baseline clinical model.

18 March 2025 in Journal of Neuro-Oncology
Verified
Journal Article
Open access
PDF file
ANAlice Neimantaite
Alice Neimantaite
LCLouise Carstam
Louise Carstam
TVTomás Gómez Vecchio
Tomás Gómez Vecchio
IHIda Häggström
Ida Häggström
TDTora Dunås
Tora Dunås
AJAsgeir S. Jakola
Asgeir S. Jakola
Purpose: Adult patients with diffuse lower-grade gliomas (dLGG) show heterogeneous survival outcomes, complicating postoperative treatment planning. Treating all patients early increases the risk of long-term side effects, while delayed treatment may lead to impaired survival. Refinement of prognostic models could optimize timing of treatment. Conventional radiological features are prognostic in dLGG, but MRI could carry more prognostic information. This study aimed to investigate MRI-based radiomics survival models and compare them with clinical models. Methods: Two clinical survival models were created: a preoperative model (tumor volume) and a full clinical model (tumor volume, extent of resection, tumor subtype). Radiomics features were extracted from preoperative MRI. The dataset was divided into training set and unseen test set (70:30). Model performance was evaluated on test set with Uno’s concordance index (c-index). Risk groups were created by the best performing model’s predictions. Results: 207 patients with mutated IDH (mIDH) dLGG were included. The preoperative clinical, full clinical and radiomics models showed c-indexes of 0.70, 0.71 and 0.75 respectively on test set for overall survival. The radiomics model included four features of tumor diameter and tumor heterogeneity. The combined full clinical and radiomics model showed best performance with c-index = 0.79. The survival difference between high- and low-risk patients according to the combined model was both statistically significant and clinically relevant. Conclusion: Radiomics can capture quantitative prognostic information in patients with dLGG. Combined models show promise of synergetic effects and should be studied further in astrocytoma and oligodendroglioma patients separately for optimal modelling of individual risks.

8 March 2025 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
ANAlice Neimantaite
Alice Neimantaite
TVTomás Gómez Vecchio
Tomás Gómez Vecchio
IRIsabelle Rydén
Isabelle Rydén
DHDima Harba
Dima Harba
AJAsgeir S. Jakola
Asgeir S. Jakola
ASAnja Smits
Anja Smits
Purpose: Patients with diffuse lower-grade gliomas (LGG) often suffer from mental fatigue. In healthy subjects, mental fatigue has a negative impact on cognitive functioning. This relation may be more complex in LGG, where tumor localization and growth rate also impact brain function. Our aim was to investigate how self- and observer-reported variables of mental fatigue and cognitive functioning were connected before tumor treatment. Methods: Consecutive patients scheduled for surgery due to presumed LGG were screened (n = 157). LGG was presumed if the mass was suggestive of diffuse glioma, but without significant contrast enhancement. Isocitrate dehydrogenase (IDH)-mutated WHO grade 2 or 3 gliomas (the LGG group) were analyzed separately. We included 101 patients in the entire cohort, whereas 71 patients constituted the LGG group. Patient data included: (1) self-reported assessments of mental fatigue and cognitive functioning, (2) neuropsychological test performances, and (3) clinical/demographic characteristics. Spearman's partial correlations were calculated between the variables and visualized in a correlation network. Results: Cognitive impairment was self-reported by 50% of the entire cohort and 45% of the LGG group, while observer-evaluated testing showed cognitive impairment in 40% and 34% of the cases respectively. Self-reported assessments showed no correlations (≥ 0.3 or ≤-0.3) with neuropsychological test performances. A consistent correlation was seen between self-reported mental fatigue and self-reported cognitive functioning (entire cohort: rho=-0.66, LGG group: -0.64). Conclusion: Our results highlight the complexity of evaluating symptoms of mental fatigue and cognitive functioning even prior to surgery. Self-reports and neuropsychological testing were weakly correlated, hence these should be handled complimentary.

9 November 2025 in Neuro-Oncology
Verified
Journal Article
Open access
IRIsabelle Rydén
Isabelle Rydén
Francesco LatiniFrancesco Latini
Francesco Latini
ÅMÅsa Alberius Munkhammar
Åsa Alberius Munkhammar
PHPer Hellström
Per Hellström
ANAlice Neimantaite
Alice Neimantaite
AJAsgeir Jakola
Asgeir Jakola
Background: Management of isocitrate dehydrogenase (IDH) mutated gliomas is multidisciplinary and current guidelines support early multimodal treatment. The effects of this treatment approach on cognition are less studied. We aimed to study changes in cognitive functioning the first year following treatment in these patients and explore predictors of cognitive deterioration. Methods: Patients with a first-time diagnosis of IDH mutated glioma were neuropsychologically assessed before and one year after surgery. Results were compared to published norms, and impairment defined as z <−1.645. Matched controls were assessed at corresponding times, and reliable change indices (RCIs) were calculated to account for practice effects. Logistic regression models investigated predictors for cognitive declines. Tumor locations for declined versus non-declined patients were visualized using heatmaps. Results: Of the 127 included patients, 104 underwent multi-modal treatment. Pre-operative impairments ranged from 3% to 24%, depending on the specific test. Cognitive declines according to RCI domains were largest in tests of executive functioning (24%), learning/memory (23%), and language (21%). Tests of inhibition/flexibility (32%), naming speed (29%), verbal memory (28%), object naming (28%), and verbal fluency (22%) showed the largest proportions of declines. Regression models revealed that older age and chemoradiotherapy predicted declines in specific domains as well as in individual tests (P < 0.05). Conclusions: Significant changes occurred in several cognitive domains after guideline-based treatment. Older age and chemoradiotherapy increased the risk of cognitive declines one year after surgery, but to which extent the deficits are persistent or progressing remains unknown.

24 December 2025 in Brain and Spine
Verified
Journal Article
Open access
SLSophia M. Leiss
Sophia M. Leiss
MJMargret Jensdottir
Margret Jensdottir
OSOle Solheim
Ole Solheim
ACAlba Corell
Alba Corell
ALAnna Lipatnikova
Anna Lipatnikova
AJAsgeir Jakola
Asgeir Jakola
Maximal safe resection is established goal of WHO grade 2 low-grade gliomas (LGG). Asleep motor mapping offers an alternative to awake surgery for tumors near motor areas and has been shown to be safe and effective in expert centers. We aimed to identify predictors of postoperative motor deficits, and describe patient selection and intraoperative mapping techniques across Scandinavian centers. We retrospectively analyzed patients (≥18) with WHO grade 2 gliomas who underwent asleep motor mapping across multiple Scandinavian neurosurgical centers. Clinical, surgical, and imaging data were extracted from medical records. The primary outcome was registered permanent postoperative motor deficits at 3 months. Associations with pre-, intraoperative, and radiological variables - including diffusion-weighted imaging (DWI) changes - were assessed using univariate and multivariate logistic regression. We included 74 patients from eight institutions. Median age was 48 years, 38 (51.4 %) were female and median preoperative tumor volume was 43.2 ml. 13 (17.6 %) patients achieved gross-total resection and median postoperative volume was 7.8 ml. Permanent postoperative motor deficits occurred in 19 cases (25.7 %), and 5 (6.8 %) were considered major deficits. In univariate analysis, preoperative motor deficits (p = 0.009), postoperative DWI changes (p = 0.022), and age (p = 0.043) were significantly associated with new or worsened permanent deficits. Only DWI changes and age was confirmed in penalized multivariate logistic regression. Postoperative motor deficits were common despite use of asleep motor mapping. Preoperative motor deficits and diffusion-weighted imaging changes are predictors of permanent motor deficits in this setting.

24 May 2026 in Neuro-Oncology Practice
Verified
Journal Article
Open access
IRIsabelle Rydén
Isabelle Rydén
DBDongni Buvarp
Dongni Buvarp
ANAlice Neimantaite
Alice Neimantaite
LCLouise Carstam
Louise Carstam
DHDima Harba
Dima Harba
AJAsgeir Jakola
Asgeir Jakola
Background: Cognitive impairment, fatigue, and reduced health-related quality of life (HRQoL) are common in patients with IDH-mutant gliomas. However, it remains unclear which cognitive domains are most relevant for global HRQoL, how fatigue relates to these associations, and whether this differs across disease stages. This cross-sectional study examined associations between impairments in cognitive domains and global HRQoL across the disease trajectory. Methods: Objective neuropsychological test results from patients with IDH-mutant gliomas were evaluated preoperatively, at 1 year, and long-term (≥ 5 years). Results were classified into 6 cognitive domains. HRQoL was assessed using the EORTC QLQ-C30 global health score. Hierarchical regression models were applied at each time point, adjusting for age and sex. Sensitivity analyses examined the contribution of fatigue and anxiety/depression. Results: Preoperatively (n = 106 patients), impairments in cognitive domains significantly explained additional variance beyond demographic variables (ΔR² = 0.20, p < .001), with impairments in learning/memory associated with lower global HRQoL (p < .001). At 1 year (n = 106 patients), cognitive domains also explained additional variance (ΔR ² = 0.16, p < .01), with language (p < .05) and executive impairments (p < .01) as significant predictors. In the long-term cohort (n = 82 patients), cognitive domains explained additional variance (ΔR² = 0.31, p < .001), with executive impairments showing the strongest association (p < .001). Fatigue was strongly associated with global HRQoL across time points (p < .001). Anxiety/depression showed weaker associations. Conclusions: Associations between cognitive functioning and global HRQoL differ across time points, with executive impairments showing the strongest associations. Fatigue represents an important co-occurring factor. These symptoms are potentially modifiable, indicating that rehabilitation may improve patients’ HRQoL.